Splenomegaly as risk factor of liver cirrhosis. A retrospective cohort study of 2,525 patients who underwent laparoscopy.

In Vivo

Department of Medical and Surgical Sciences, School of Medicine, University of Padua, via Giustiniani 2, 35128 Padova, Italy.

Published: March 2012

The aim of this study was to evaluate the meaning of laparoscopic splenomegaly and its relationship with the severity and evolution of liver cirrhosis. Medical records of 2,525 consecutive patients with chronic liver diseases who underwent laparoscopy and video-guided hepatic biopsy were reviewed. There were 1,610 (63.8%) men and 915 (36.2%) women. All patients underwent gastroscopy to diagnose esophageal varices. The diagnosis of cirrhosis was made in 910 (36.0%) patients, while 620 (24.6%) had hepatic fibrosis, and 995 (39.4%) chronic active hepatitis. Splenomegaly was present in 460 out of 910 patients (50.5%) with cirrhosis. Among the 1,615 patients without cirrhosis, splenomegaly was present in 80 (4.9%), and esophageal varices were present in 70 out of 910 (7.6%) cirrhotic patients. In patients without cirrhosis, esophageal varices were present in 30 out of 1,615 (1.2%) at the time of laparoscopy. Statistical analysis showed significant differences between patients with cirrhosis and without cirrhosis for splenomegaly (χ(2)=717.03, p<0.001) and esophageal varices (χ(2)=50.57, p<0.001). In conclusion, laparoscopic splenomegaly seems to be an important prognostic factor in liver cirrhosis, which represents a risk factor for portal hypertension.

Download full-text PDF

Source

Publication Analysis

Top Keywords

esophageal varices
12
patients cirrhosis
12
patients
9
cirrhosis
8
liver cirrhosis
8
patients underwent
8
underwent laparoscopy
8
cirrhosis splenomegaly
8
splenomegaly
5
splenomegaly risk
4

Similar Publications

BACKGROUND Arterioportal fistulas (APFs) are abnormal connections between the arterial and portal venous systems, leading to portal hypertension (PH) and symptoms such as gastrointestinal bleeding, splenomegaly, and hepatic pain. Symptoms typically appear by the age of 2 years in about 75% of cases. CASE REPORT A 7-year-old boy with an asymptomatic APF developed life-threatening complications following a Clostridium difficile infection.

View Article and Find Full Text PDF

Background And Purpose: Esophageal and gastric varices hemorrhage (EGVH) is a life-threatening condition with the 6-week mortality rate of 15-25%. Up to 60% of patients with EGVH may experience rebleeding with a mortality rate of 33%. The existing scoring systems, such as RS scoring system (Rockall score, RS) and GBS scoring system (Glasgow-Blatchford score, GBS), have limitations in predicting the risk of rebleeding.

View Article and Find Full Text PDF

Objective: To develop and compare machine learning models based on CT morphology features, serum biomarkers, and basic physical conditions to predict esophageal variceal bleeding.

Materials And Methods: Two hundred twenty-four cirrhotic patients with esophageal variceal bleeding and non-bleeding were included in the retrospective study. Clinical and serum biomarkers were used in our study.

View Article and Find Full Text PDF

Aim: This study aims to evaluate the outcomes of endoscopic sclerotherapy (EST) in the treatment of esophagogastric varices in cases of extrahepatic portal hypertension (EHPH) secondary to portal vein thrombosis.

Materials And Methods: Records of cases that underwent endoscopic sclerotherapy for esophagogastric varices between 1990 and 2022 in our clinic were retrospectively reviewed. The age, gender, symptomatology, etiology, clinical, laboratory, and radiological data of the patients, as well as treatment outcomes, were evaluated.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!